RxDoctor Payments Data

Jodi-Ann Lewis

Psychiatric/Mental Health · Reading, PANPI 1194589101

Payments from drug & device makers

$2,864in general payments, 2019–2025

Across 105 payments — averaging $27.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$581
  • AbbVie$536
  • Axsome Therapeutics, Inc.$310
  • E.r. Squibb & Sons, L.L.C.$290
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$206
  • Vanda Pharmaceuticals Inc.$203
  • plus $737 from 7 others

What the payments were for

  • Food & beverage$2,864100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,864 in reported general payments places this provider in the 80th percentile of 1,041 psychiatric/mental health providers in Pennsylvania.

See all psychiatric/mental health providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$3,018
Medicare patients
13
Services billed
32

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Bupropion XlBupropion Hcl22$2,713
Fluoxetine Hcl20$571
Duloxetine Hcl25$509
Venlafaxine Hcl ErVenlafaxine Hcl20$449
Mirtazapine23$446
Quetiapine Fumarate35$437
Lamotrigine22$418
Buspirone Hcl30$397
Olanzapine27$391
Aripiprazole16$344
Trazodone Hcl32$333
Clonazepam58$288
Hydroxyzine Hcl14$231
Sertraline Hcl23$223
Gabapentin11$169

Paid to pharmacies, not to this prescriber.

Other psychiatric/mental health in Reading

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →